Sun Pharma receives USFDA nod for anti-anxiety drug

21 Jun 2010 Evaluate

Sun Pharmaceutical Industries has received the US Food and Drug Administration's nod to market a generic version of alprazolam, an anti-anxiety drug, in the US market. The company has received the USFDA's nod for marketing generic alprazolam tablets in four strengths, 0.25 mg, 0.55 mg, 1 mg and 2 mg, in the US market.

Generic alprazolam tablets are equivalent to Pfizer's patented Xanax tablets. Alprazolam has annual sales of USD 145 million in the United States. On Thursday, the company had received the US health regulator's nod for marketing a generic version of the Keppra injection, used for treating epilepsy, in the American market.

crackcrack

Sun Pharma Inds. Share Price

1719.20 -18.30 (-1.05%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×